BCRB 2018

Late effects – Dose-effect relationship

100

high

dose

follow -up

clinically relevant effect

interm. dose

severity

frequency [%] 0

low dose

FU1

FU2

dose

time [years]

Tolerance doses for late responding tissues require information on the duration of follow up!

ESTRO BCR Course / Pathogenesis of NT effects – W. Dörr